{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:27Z","timestamp":1791920127870,"version":"4.3.4"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T00:00:00Z","timestamp":1282521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0012333","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T20:45:25Z","timestamp":1282596325000},"page":"e12333","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":107,"title":["Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in \u03b1-Synuclein Overexpressing Mice"],"prefix":"10.1371","volume":"5","author":[{"given":"Joanne","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Clore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangni","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,8,23]]},"reference":[{"issue":"R2","key":"ref1","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1093\/hmg\/ddm159","article-title":"Parkinson's disease.","volume":"16","author":"B Thomas","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2007.02036.x","article-title":"Progress in Parkinson's disease.","volume":"15","author":"AH Schapira","year":"2008","journal-title":"Eur J Neurol"},{"issue":"Suppl","key":"ref3","first-page":"S116","article-title":"Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.","volume":"32","author":"AH Schapira","year":"1992","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S1353-8020(03)00023-3","article-title":"The rotenone model of Parkinson's disease: genes, environment and mitochondria.","volume":"9","author":"JT Greenamyre","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The etiology of Parkinson's disease with emphasis on the MPTP story.","volume":"47","author":"JW Langston","year":"1996","journal-title":"Neurology"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4439(97)00070-7","article-title":"Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.","volume":"1362","author":"DS Cassarino","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 2","key":"ref7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1042\/bj20021121","article-title":"Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state.","volume":"368","author":"Y Kushnareva","year":"2002","journal-title":"Biochem J"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered a-Synuclein Metabolism and Oxidative Damage.","volume":"22","author":"TB Sherer","year":"2002","journal-title":"J Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease.","volume":"53","author":"P Jenner","year":"2003","journal-title":"Ann Neurol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0304-3940(82)90390-1","article-title":"Parkinson's disease: a disorder due to nigral glutathione deficiency?","volume":"33","author":"TL Perry","year":"1982","journal-title":"Neurosci Lett"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.","volume":"9","author":"DT Dexter","year":"1994","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/JMN:23:1-2:023","article-title":"Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's disease.","volume":"23","author":"JC Rochet","year":"2004","journal-title":"J Mol Neurosci"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.","volume":"8","author":"J Xu","year":"2002","journal-title":"Nat Med"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0002-9440(10)64781-5","article-title":"Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.","volume":"157","author":"JE Duda","year":"2000","journal-title":"Am J Pathol"},{"issue":"24","key":"ref15","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M000206200","article-title":"Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.","volume":"275","author":"JM Souza","year":"2000","journal-title":"J Biol Chem"},{"issue":"5493","key":"ref16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective alpha- synuclein nitration in synucleinopathy lesions.","volume":"290","author":"BI Giasson","year":"2000","journal-title":"Science"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-199903170-00011","article-title":"Oxidative stress induces amyloid-like aggregate formation of NACP\/alpha-synuclein in vitro.","volume":"10","author":"M Hashimoto","year":"1999","journal-title":"Neuroreport"},{"issue":"20","key":"ref18","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult.","volume":"21","author":"E Paxinou","year":"2001","journal-title":"J Neurosci"},{"issue":"5545","key":"ref19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic Stabilization of the alpha -Synuclein Protofibril by a Dopamine- alpha -Synuclein Adduct.","volume":"294","author":"KA Conway","year":"2001","journal-title":"Science"},{"issue":"5456","key":"ref20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.","volume":"287","author":"E Masliah","year":"2000","journal-title":"Science"},{"issue":"9440","key":"ref21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.","volume":"364","author":"P Ibanez","year":"2004","journal-title":"Lancet"},{"issue":"9440","key":"ref22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.","volume":"364","author":"MC Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease.","volume":"302","author":"AB Singleton","year":"2003","journal-title":"Science"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(98)00894-5","article-title":"N-acetylcysteine, but not methionine or 2-oxothiazolidine-4-carboxylate, serves as cysteine donor for the synthesis of glutathione in cultured neurons derived from embryonal rat brain.","volume":"259","author":"R Dringen","year":"1999","journal-title":"Neurosci Lett"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s000180300001","article-title":"Molecular mechanisms of N-acetylcysteine actions.","volume":"V60","author":"M Zafarullah","year":"2003","journal-title":"Cellular and Molecular Life Sciences (CMLS)"},{"issue":"15","key":"ref26","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1158\/0008-5472.CAN-04-0442","article-title":"Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice.","volume":"64","author":"R Reliene","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0197-0186(99)00126-6","article-title":"In-vivo glutathione elevation protects against hydroxyl free radical- induced protein oxidation in rat brain.","volume":"36","author":"CB Pocernich","year":"2000","journal-title":"Neurochem Int"},{"issue":"1","key":"ref28","article-title":"N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson's disease.","volume":"859","author":"MM Banaclocha","year":"2000","journal-title":"Brain Res"},{"issue":"1\u20132","key":"ref29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0006-8993(97)00493-9","article-title":"N-acetylcysteine protects against age-related increase in oxidized proteins in mouse synaptic mitochondria.","volume":"762","author":"MM Banaclocha","year":"1997","journal-title":"Brain Res"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01958877","article-title":"Effects of cysteine and N-acetyl cysteine on GSH content of brain of adult rats.","volume":"39","author":"J Vina","year":"1983","journal-title":"Experientia"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0006-2952(66)90197-3","article-title":"Metabolic studies with acetylcysteine.","volume":"15","author":"AL Sheffner","year":"1966","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3940(85)90229-0","article-title":"Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.","volume":"60","author":"TL Perry","year":"1985","journal-title":"Neurosci Lett"},{"issue":"1","key":"ref33","first-page":"48","article-title":"Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.","volume":"53","author":"A Sharma","year":"2007","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"8","key":"ref34","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease.","volume":"57","author":"JC Adair","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1054\/mehy.2000.1194","article-title":"Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases.","volume":"56","author":"MM Banaclocha","year":"2001","journal-title":"Med Hypotheses"},{"issue":"15","key":"ref36","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0024-3205(98)00472-X","article-title":"Hypothesis: can N-acetylcysteine be beneficial in Parkinson's disease?","volume":"64","author":"M Martinez","year":"1999","journal-title":"Life Sci"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1212\/01.WNL.0000058760.13152.1A","article-title":"Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment.","volume":"60","author":"BM Ravina","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nn1609","article-title":"Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.","volume":"9","author":"K Aoyama","year":"2006","journal-title":"Nat Neurosci"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2009.11.009","article-title":"Ghrelin prevents 1-methyl-4-phenylpyridinium ion-induced cytotoxicity through antioxidation and NF-kappaB modulation in MES23.5 cells.","volume":"222","author":"L Liu","year":"2010","journal-title":"Exp Neurol"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/hmg\/ddp501","article-title":"Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling.","volume":"19","author":"D Sha","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yexmp.2008.10.004","article-title":"Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.","volume":"86","author":"E Aoki","year":"2009","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14728222.11.2.123","article-title":"NF-kB as a therapeutic target in neurodegenerative diseases.","volume":"11","author":"S Camandola","year":"2007","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI118106","article-title":"Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress.","volume":"96","author":"LM Khachigian","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005344-200407000-00004","article-title":"Roles of NF-kappaB and SP-1 in oxidative stress-mediated induction of platelet-derived growth factor-B by TNFalpha in human endothelial cells.","volume":"44","author":"J Shi","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 2","key":"ref45","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.parkreldis.2008.04.004","article-title":"Strengths and limitations of genetic mouse models of Parkinson's disease.","volume":"14","author":"MF Chesselet","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb07475.x","article-title":"Transgenic models of alpha-synuclein pathology: past, present, and future.","volume":"991","author":"M Hashimoto","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.21022","article-title":"Genetics of Parkinson's disease and parkinsonism.","volume":"60","author":"J Hardy","year":"2006","journal-title":"Annals of Neurology"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/mds.10173","article-title":"Genetics of parkinsonism.","volume":"17","author":"K Gwinn-Hardy","year":"2002","journal-title":"Mov Disord"},{"issue":"7","key":"ref49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929867013372995","article-title":"Parkinson's disease\u2013redox mechanisms.","volume":"8","author":"JD Adams Jr","year":"2001","journal-title":"Curr Med Chem"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.expneurol.2005.10.018","article-title":"Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection.","volume":"199","author":"MC Quilty","year":"2006","journal-title":"Exp Neurol"},{"issue":"47","key":"ref51","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","article-title":"Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.","volume":"104","author":"A Ghosh","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct Transfer of a-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies.","volume":"285","author":"H-J Lee","year":"2010","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1756-6606-3-12","article-title":"Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.","volume":"3","author":"X-L Gu","year":"2010","journal-title":"Molecular Brain"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.","volume":"22","author":"D Kirik","year":"2002","journal-title":"J Neurosci"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1073\/pnas.0536383100","article-title":"Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.","volume":"100","author":"D Kirik","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exnr.2002.7882","article-title":"Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.","volume":"175","author":"EK Richfield","year":"2002","journal-title":"Exp Neurol"},{"issue":"4","key":"ref57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.0953-816X.2004.03139.x","article-title":"Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.","volume":"19","author":"MJ Thiruchelvam","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ajhp\/56.11.1081","article-title":"Treatment of acetaminophen overdose.","volume":"56","author":"PJ Zed","year":"1999","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1097\/00001756-200008030-00029","article-title":"N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis.","volume":"11","author":"OA Andreassen","year":"2000","journal-title":"Neuroreport"},{"issue":"7","key":"ref60","first-page":"1642","article-title":"Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs.","volume":"56","author":"R Balansky","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues.","volume":"27","author":"F Tietze","year":"1969","journal-title":"Anal Biochem"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0003-2697(80)90139-6","article-title":"Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine.","volume":"106","author":"OW Griffith","year":"1980","journal-title":"Anal Biochem"},{"issue":"1","key":"ref63","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/exnr.1997.6673","article-title":"Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture.","volume":"149","author":"JJ Vornov","year":"1998","journal-title":"Exp Neurol"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.2042-7158.1968.tb09743.x","article-title":"The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod.","volume":"20","author":"BJ Jones","year":"1968","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"ref65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","volume":"178","author":"JL Tillerson","year":"2002","journal-title":"Exp Neurol"},{"issue":"3","key":"ref66","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice.","volume":"50","author":"N Ogawa","year":"1985","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion.","volume":"73","author":"K Matsuura","year":"1997","journal-title":"Journal of Neuroscience Methods"},{"issue":"42","key":"ref68","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.","volume":"24","author":"SM Fleming","year":"2004","journal-title":"J Neurosci"},{"issue":"34","key":"ref69","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","article-title":"Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.","volume":"104","author":"KS Rommelfanger","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0012333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:41:08Z","timestamp":1589038868000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0012333"}},"subtitle":[],"editor":[{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,8,23]]},"references-count":69,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,8,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0012333","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,23]]}}}